Related Experiment Video
Updated: May 29, 2026

08:35
Achieving Efficient Fragment Screening at XChem Facility at Diamond Light Source
Published on: May 29, 2021
SERAPhiC: a benchmark for in silico fragment-based drug design
Angelo D Favia1, Giovanni Bottegoni, Irene Nobeli
1Department of Drug Discovery and Development, Istituto Italiano di Tecnologia, via Morego 30, 16163 Genova, Italy. angelo.favia@iit.it
Journal of Chemical Information and Modeling
|September 23, 2011
Summary
A new dataset of protein-fragment complexes, SERAPhiC, is now available. This resource aids in evaluating molecular docking protocols and scoring functions for drug discovery.
Area of Science:
- Computational chemistry
- Structural biology
- Drug discovery
Background:
- High-quality datasets are crucial for validating computational methods in structural biology.
- Protein-fragment complex data is essential for understanding binding interactions and developing new drugs.
Purpose of the Study:
- To create and release a curated dataset of high-quality protein-fragment complexes.
- To assess the accuracy of molecular docking in reproducing experimental structures.
- To determine optimal sampling strategies for docking simulations.
- To evaluate the performance of scoring functions in distinguishing native poses.
Main Methods:
- Compilation of a selected set of protein-fragment complexes.
- Application of molecular docking procedures to the dataset.
- Analysis of sampling thoroughness and scoring function efficacy.
Main Results:
- The SERAPhiC dataset provides a reliable benchmark for computational medicinal chemistry.
- The study addresses key questions regarding the accuracy and requirements of molecular docking.
- The dataset is available in a ready-to-dock format for immediate use.
Conclusions:
- The SERAPhiC dataset is a valuable resource for in silico protocol assessment and software development.
- It facilitates the advancement of molecular docking techniques for drug discovery.
- Publicly available, high-quality data is vital for progress in computational drug design.

